We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+9.17%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
–
AUM
$393M
AUM Growth
+$34.5M
Cap. Flow
+$5.89M
Cap. Flow %
1.5%
Top 10 Hldgs %
23.79%
Holding
1,179
New
38
Increased
165
Reduced
258
Closed
39

Top Buys

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$2.92M
2
UNH icon
UnitedHealth
UNH
+$1.26M
3
MSFT icon
Microsoft
MSFT
+$1.18M
4
T icon
AT&T
T
+$795K
5
JPM icon
JPMorgan Chase
JPM
+$780K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$704K
2
VMC icon
Vulcan Materials
VMC
+$500K
3
AKAM icon
Akamai
AKAM
+$461K
4
FIS icon
Fidelity National Information Services
FIS
+$449K
5
LHX icon
L3Harris
LHX
+$440K

Sector Composition

Rank Sector Weight
1 Technology 22.29%
2 Healthcare 13.57%
3 Financials 12.77%
4 Consumer Discretionary 8.62%
5 Communication Services 7.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SXT icon
1026
Sensient Technologies
SXT
$5.28B
$4K ﹤0.01%
54
– –
TCRT icon
1027
Alaunos Therapeutics
TCRT
$4.59M
$4K ﹤0.01%
5
– –
TDC icon
1028
Teradata
TDC
$2.88B
$4K ﹤0.01%
112
– –
TEAM icon
1029
Atlassian
TEAM
$24.9B
$4K ﹤0.01%
20
– –
TME icon
1030
Tencent Music
TME
$15.5B
$4K ﹤0.01%
230
– –
TOKE
1031
DELISTED
Cambria Cannabis ETF
TOKE
$4K ﹤0.01%
200
– –
TROW icon
1032
T. Rowe Price
TROW
$25.6B
$4K ﹤0.01%
32
– –
VANI icon
1033
Vivani Medical
VANI
$112M
$4K ﹤0.01%
195
– –
VSEC icon
1034
VSE Corp
VSEC
$5.37B
$4K ﹤0.01%
82
– –
VYGR icon
1035
Voyager Therapeutics
VYGR
$189M
$4K ﹤0.01%
286
– –
VYX icon
1036
NCR Voyix
VYX
$1.12B
$4K ﹤0.01%
163
– –
W icon
1037
Wayfair
W
$11.9B
$4K ﹤0.01%
36
– –
WCC
1038
WESCO International
WCC
$16.7B
$4K ﹤0.01%
62
-3,030
-98% -$158K
WIT icon
1039
Wipro
WIT
$19.3B
$4K ﹤0.01%
1,532
– –
WKC icon
1040
World Kinect Corp
WKC
$2.03B
$4K ﹤0.01%
78
– –
WTRG icon
1041
Essential Utilities
WTRG
$11.4B
$4K ﹤0.01%
68
-344
-83% -$15.5K
XBI icon
1042
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$4K ﹤0.01%
40
– –
XRX icon
1043
Xerox
XRX
$456M
$4K ﹤0.01%
60
– –
XSHD icon
1044
Invesco S&P SmallCap High Dividend Low Volatility ETF
XSHD
$72.2M
$4K ﹤0.01%
100
– –
XTL icon
1045
State Street SPDR S&P Telecom ETF
XTL
$558M
$4K ﹤0.01%
44
– –
XTNT icon
1046
Xtant Medical Holdings
XTNT
$60.6M
$4K ﹤0.01%
1,258
– –
XXII
1047
22nd Century Group
XXII
$1.34M
– –
0
– –
Z icon
1048
Zillow
Z
$7.71B
$4K ﹤0.01%
50
– –
ZBH icon
1049
Zimmer Biomet
ZBH
$18.4B
$4K ﹤0.01%
23
– –
ZYME icon
1050
Zymeworks
ZYME
$1.67B
$4K ﹤0.01%
50
– –
40 41
42
43 44

Similar funds

PJB
Paul John Balson Marina Del Rey, California $486M AUM 78.12% 1-Year Est. Return
IVA
International Value Advisers $615M AUM 6.37% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
PSSGI
P-STS SPV GP IA San Francisco, California $433M AUM
AVAX
Atlas Venture Associates XI Cambridge, Massachusetts $631M AUM
DK
Darrell & King Charlottesville, Virginia $633M AUM 49.4% 1-Year Est. Return
MCM
Matarin Capital Management New York $409M AUM 33.03% 1-Year Est. Return
GBBWRPM
Genovese Burford & Brothers Wealth & Retirement Plan Management Sacramento, California $400M AUM 14.87% 1-Year Est. Return

Winslow Evans & Crocker's Q4 2019 Portfolio in Review

As of Q4 2019, Winslow Evans & Crocker held 1,179 positions worth $393M, up 9.6% from $358M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Winslow Evans & Crocker's Q4 2019 filing shows 38 new, 165 increased, 258 reduced and 39 closed positions. Its largest new stake was Kansas City Southern: 2,476 shares worth $380K. The largest sale was Celgene Corp, an estimated $704K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Winslow Evans & Crocker's largest Q4 2019 buy was Kansas City Southern: 2,476 shares worth $380K.
  • Winslow Evans & Crocker added most to Global Payments in Q4 2019, an estimated $2.92M increase.
  • Winslow Evans & Crocker's biggest Q4 2019 reduction was Akamai, cutting an estimated $461K.
  • Winslow Evans & Crocker fully exited Celgene Corp in Q4 2019, selling an estimated $704K.
  • Winslow Evans & Crocker's ten largest holdings make up 24% of its $393M portfolio in Q4 2019.
  • Winslow Evans & Crocker opened 38 new positions and closed 39 in Q4 2019.
  • Winslow Evans & Crocker's portfolio value rose 9.6% quarter-over-quarter to $393M.

Based on Winslow Evans & Crocker's 13F filing for Q4 2019, filed 14 Jan 2020.